동아시아식생활학회지 (Journal of the East Asian Society of Dietary Life)

  • 제25권5호
  • /
  • Pages.806-812
  • /
  • 2015
  • /
  • 1225-6781(pISSN)
  • /
  • 2288-8802(eISSN)
동아시아식생활학회 (The East Asian Society of Dietary Life)
권호 표지
DOI QR코드

DOI QR Code

전립선 비대유도 쥐의 전립선 조직에서 울금 급여에 따른 염증인자의 변화

Effect of Hot Water Extract from Curcuma longa L. on Inflammatory Mediators in Prostate Tissue of BPH-Induced Rats

  • 투고 : 2015.09.24
  • 심사 : 2015.10.16
  • 발행 : 2015.10.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

본 연구에서는 테스토스테론으로 전립선 비대를 유도한 래트에 울금(Curcuma longa L.)의 열수추출물을 다양한 농도로 급여하여 그에 따른 염증인자의 변화를 검토하였다. 조직학적 분석에서 울금 열수추출물(CL) 급여에 따라 전립선비대가 완화되는 것을 검토할 수 있었으며, 염증성 사이토카인인 TNF-${\alpha}$, IL-6 및 IL-$1{\beta}$이 전립선 비대 유도군에서 그 발현이 현저히 증가하였으나, 각 농도의 CL 군에서는 농도의존적으로 감소하였다. 또한, CL 급여에 따라 finasteride enzyme인 COX-2와 염증 전사인자인 NF-${\kappa}b$의 활성화의 감소를 확인하였다. 이와 같은 결과는 전립선 비대에서 울금 열수추출물이 항염증 효과로써 전립선 비대의 유발 및 발전을 억제시킬 수 있다는 것을 부분적으로나마 설명할 수 있는 기초 자료가 될 수 있다고 사료된다.

Prostatic inflammation plays a crucial role on benign prostate hyperplasia (BPH) pathogenesis and progression. In this study, BPH was induced by testosterone propinate in castrated rats for 8 weeks. Hot water extract from Curcuma longa L. (CL) was administered orally for 4 weeks along with positive controls, saw Palmetto and finasteride. CL supplementation induced histological changes, reduced expression of TNF-${\alpha}$, IL-6, IL-$1{\beta}$, COX-2, and phospo-p65 in prostate tissue compared with the BPH group. These findings suggest that suppression of pro-inflammatory cytokines could be attributed, at least partly, to the anti-inflammatory action of C. longa, and this action may be helpful to understand the inhibitory effect of Curcuma longa L. in BPH.

키워드

참고문헌

  1. Ahmad M, Suhail N, Mansoor T, Banu N, Ahmad S (2012) Evaluation of oxidative stress and DNA damage in benign prostatic hyperplasia patients and comparison with controls. Indian J Clin Biochem 27: 385-388. https://doi.org/10.1007/s12291-012-0229-4
  2. Aryal M, Pandeya A, Bas BK, Lamsal M, Majhi S, Pandit R, Agrawal CS, Gautam N, Baral N (2007) Oxidative stress in patients with benign prostate hyperplasia. J Nepal Med Assoc 46: 103-106.
  3. Atawia RT, Mosli HH, Tadros MG, Khalifa AE, Mosli HA, Abdel-Naim AB (2014) Modulatory effect of silymarin on inflammatory mediators in experimentally induced benign prostatic hyperplasia: Emphasis on PTEN, HIF-$1{\alpha}$, and NF-${\kappa}B$. Naunyn Schmiedebergs Arch Pharmacol 387: 1131-1140. https://doi.org/10.1007/s00210-014-1040-y
  4. Bernichtein S, Pigat N, Camparo P, Latil A, Viltard M, Friedlander G, Goffin V (2015) Anti-inflammatory properties of lipidosterolic extract of Serenoa repens ($Permixon^{(R)}$) in a mouse model of prostate hyperplasia. Prostate 75: 706-22. https://doi.org/10.1002/pros.22953
  5. Berry SJ, Coffey DS, Walsh PC, Ewing LL (1984) The development of human benign prostatic hyperplasia with age. J Urol 132: 474-479. https://doi.org/10.1016/S0022-5347(17)49698-4
  6. Bostanci Y, Kazzazi A, Momtahen S, Laze J, Djavan B (2013) Correlation between benign prostatic hyperplasia and inflammation. Curr Opin Urol 23: 5-10. https://doi.org/10.1097/MOU.0b013e32835abd4a
  7. Elberry AA, Mufti ST, Al-Maghrabi JA, Abdel-Sattar EA, Ashour OM, Ghareib SA, Mosli HA (2011) Anti-inflammatory and antiproliferative activities of date palm pollen (Phoenix dactylifera) on experimentally-induced atypical prostatic hyperplasia in rats. J Inflamm (Lond) 8: 40-53. https://doi.org/10.1186/1476-9255-8-40
  8. Elberry AA, Mufti S, Al-Maghrabi J, Abdel Sattar E, Ghareib SA, Mosli HA, Ghareib SA (2014) Immunomodulatory effect of red onion (Allium cepa Linn) scale extract on experimentally induced atypical prostatic hyperplasia in Wistar rats. Mediators Inflamm 640746.
  9. Gandaglia G, Briganti A, Gontero P, Mondaini N, Novara G, Salonia A, Sciarra A, Montorsi F (2013) The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH). BJU Int 112: 432-441. https://doi.org/10.1111/bju.12118
  10. Ho JN, Jang JY, Yoon HG, Kim Y, Kim S, Jun W, Lee J (2012) Anti-obesity effect of a standardised ethanol extract from Curcuma longa L. fermented with Aspergillus oryzae in ob/ob mice and primary mouse adipocytes. J Sci Food Agric 92: 1833-1840. https://doi.org/10.1002/jsfa.5592
  11. Illuri R, Bethapudi B, Anandakumar S, Murugan S, Joseph JA, Mundkinajeddu D, Agarwal A, Chandrasekaran CV (2015) Anti-Inflammatory activity of polysaccharide fraction of Curcuma longa extract (NR-INF-02). Antiinflamm Antiallergy Agents Med Chem 14: 53-62. https://doi.org/10.2174/1871523014666150407150533
  12. Kim J, Jeong SW, Quan H, Jeong CW, Choi JI, Bae HB (2015) Effect of curcumin (Curcuma longa extract) on LPSinduced acute lung injury is mediated by the activation of AMPK. J Anesth Sep 3. [Epub ahead of print].
  13. Kramer G, Marberger M (2006) Could inflammation be a key component in the progression of benign prostatic hyperplasia? Curr Opin Urol 16: 25-29.
  14. Latil A, Pétrissans MT, Rouquet J, Robert G, de la Taille A (2015) Effects of hexanic extract of serenoa repens ($permixon^{(R)}$ 160 mg) on inflammation biomarkers in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia. Prostate 75:1857-1867. https://doi.org/10.1002/pros.23059
  15. McCann MJ, Johnston S, Reilly K, Men X, Burgess EJ, Perry NB, Roy NC (2014) The effect of turmeric (Curcuma longa) extract on the functionality of the solute carrier protein 22 A4 (SLC22A4) and interleukin-10 (IL-10) variants associated with inflammatory bowel disease. Nutrients 6: 4178-4190. https://doi.org/10.3390/nu6104178
  16. Minutoli L, Bitto A, Squadrito F, Marini H, Irrera N, Morgia G, Passantino A, Altavilla D (2013) Serenoa repens, lycopene and selenium: A triple therapeutic approach to manage benign prostatic hyperplasia. Curr Med Chem 20: 1306-1312. https://doi.org/10.2174/0929867311320100007
  17. Nunez C, Cansino JR, Bethencourt F, Perez-Utrilla M, Fraile B, Martinez-Onsurbe P, Olmedilla G, Paniagua R, Royuela M (2008) TNF/IL-1/NIK/NF-${\kappa}B$ transduction pathway: A comparative study in normal and pathological human prostate (benign hyperplasia and carcinoma). Histopathology 53: 166-176. https://doi.org/10.1111/j.1365-2559.2008.03092.x
  18. Park DS, Shim JY (2008) Histologic influence of doxazosin and finasteride in benign prostatic hyperplasia accompanying chronic inflammation. Urol Int 81: 441-446. https://doi.org/10.1159/000167844
  19. Roehrborn CG (2008) Pathology of benign prostatic hyperplasia. Int J Impotence Res 20: S11-S18.
  20. Shin IS, Lee MY, Jung DY, Seo CS, Ha HK, Shin HK (2012) Ursolic acid reduces prostate size and dihydrotestosterone level in a rat model of benign prostatic hyperplasia. Food Chem Toxicol 50: 884-888. https://doi.org/10.1016/j.fct.2012.01.007
  21. Sikka SC (2003) Role of oxidative stress response elements and antioxidants in prostate cancer pathobiology and chemoprevention-A mechanistic approach. Curr Med Chem 10: 2679-2692. https://doi.org/10.2174/0929867033456341
  22. Timms BG, Hofkamp LE (2011) Prostate development and growth in benign prostatic hyperplasia. Differentiation 82: 173-183. https://doi.org/10.1016/j.diff.2011.08.002
  23. Vendramini-Costa DB, Carvalho JE (2012) Molecular link mechanisms between inflammation and cancer. Curr Pharm Des 18: 3831-3852. https://doi.org/10.2174/138161212802083707

피인용 문헌

  1. RWPE-1 전립선세포에서 eritadenine을 함유한 신령버섯균사체 액체배양물의 항염증효과 및 항산화효과에 의한 전립선비대증 관련 biochemical marker 개선 효과 vol.28, pp.10, 2015, https://doi.org/10.5352/jls.2018.28.10.1147